Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 06 - 10 crawled time : 08:00 save search
Bragg Gaming Group Announces Results from Annual and Special Meeting of Shareholders
Published: 2022-06-10 (Crawled : 08:00) - bragg.games
BRAG | $5.91 -2.8% -2.88% 67K
|
Information
|
| O: 0.17%
H: 0.0%
C: -8.46%
results group
Results for 12 months ending February 28, 2022
Published: 2022-06-10 (Crawled : 08:00) - rupertresources.com
RUPRF | $2.7025 1.14% 620
|
Non-Energy Minerals
|
| O: -3.04%
H: 1.45%
C: 1.45%
AEM | $62.49 1.21% -0.3% 3.4M
|
Non-Energy Minerals
|
| O: -3.92%
H: 0.0%
C: 0.0%
AbbVie Presents Investigational Navitoclax Preliminary Data in JAK Inhibitor Naïve Myelofibrosis Patients
Published: 2022-06-10 (Crawled : 08:00) - prnewswire.com
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: -3.55%
H: 0.0%
C: 0.0%
7% of the Growth of Disposable Respiratory Masks Market to Originate from Rest of World (ROW) | Technavio
Published: 2022-06-10 (Crawled : 08:00) - prnewswire.com
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: -4.36%
H: 0.0%
C: 0.0%
RMD | $173.83 -5.97% 0.09% 3M
|
Health Technology
|
| O: -2.17%
H: 0.0%
C: 0.0%
HON | News M | $190.32 -0.21% -0.21% 2.2M
|
Producer Manufacturing
|
| O: -2.52%
H: 0.0%
C: 0.0%
respiratory growth market
Caribou Biosciences Reports Positive Additional Data from CB-010 Allogeneic CAR-T Cell Therapy Phase 1 ANTLER Trial at the European Hematology Association (EHA) 2022 Hybrid Congress
Published: 2022-06-10 (Crawled : 08:00) - globenewswire.com
CRBU | $3.92 -2.24% -2.3% 2M
|
Health Technology
|
| O: -22.27%
H: 0.0%
C: 0.0%
cb-010 car-t trial positive therapy phase 1
GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease
Published: 2022-06-10 (Crawled : 08:00) - globenewswire.com
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -6.01%
H: 0.0%
C: 0.0%
eha2022 oxbryta disease positive
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at EHA 2022
Published: 2022-06-10 (Crawled : 08:00) - globenewswire.com
IMGO | $36.01 0.03% 0.0% 0
|
Health Technology
|
| O: -7.77%
H: 0.0%
C: 0.0%
ongoing positive phase 2
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at EHA 2022
Published: 2022-06-10 (Crawled : 08:00) - globenewswire.com
IMGO | $36.01 0.03% 0.0% 0
|
Health Technology
|
| O: -7.77%
H: 0.0%
C: 0.0%
ongoing positive phase 2
Apellis and Sobi Report New Data Reinforcing the Robust Efficacy and Safety Profile of EMPAVELI® (pegcetacoplan) for PNH at EHA 2022 Congress
Published: 2022-06-10 (Crawled : 08:00) - globenewswire.com
APLS | $47.97 -7.43% -8.03% 1.7M
|
Health Technology
|
| O: -5.29%
H: 0.0%
C: 0.0%
empaveli report
Genentech Announces Positive Data from Broad Blood Cancer Portfolio at European Hematology Association Annual Meeting
Published: 2022-06-10 (Crawled : 08:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
blood positive cancer
Autolus Therapeutics Presents Clinical Data Updates at the European Hematology Association Congress
Published: 2022-06-10 (Crawled : 08:00) - globenewswire.com
AUTL | $4.85 -0.21% -0.21% 790K
|
Health Technology
|
| O: -5.43%
H: 0.0%
C: 0.0%
therapeutics
Kronos Bio Continues to Advance Investigational SYK Inhibitors Entospletinib and Lanraplenib with New Preclinical Data at EHA2022 Congress
Published: 2022-06-10 (Crawled : 08:00) - globenewswire.com
KRON | $1.03 -5.51% -5.83% 190K
|
Health Technology
|
| O: -10.63%
H: 0.0%
C: 0.0%
eha2022 preclinical pre-clinical
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.